Home » Topics » BioWorld Science

BioWorld Science
RSS

Encouraging phase I results for camrelizumab in nasopharyngeal carcinoma

Oct. 19, 2018

Dupilumab results in highly significant improvements in lung function in adolescents with asthma

Oct. 19, 2018

NeuroVive drug candidate shows efficacy in model for mitochondrial disease

Oct. 19, 2018

IPR-166 enhances cognitive performance in a schizophrenia-like mouse model

Oct. 19, 2018

First phase III results from the SAkuraSky study of satralizumab in NMOSD patients

Oct. 19, 2018

Homology Medicines' gene therapy for PKU shows promising preclinical results

Oct. 19, 2018

Midkine as a potential new biomarker of ovarian reserve in PCOS

Oct. 19, 2018

Jiangsu HengRui studies SHR-1209 in phase I in China

Oct. 19, 2018

DS Biopharma presents positive results from Advance phase IIb study of oral DS-107

Oct. 19, 2018

First-in-human study of [11C]JNJ-54173717, a PET tracer for assessing neuroinflammation

Oct. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...